A detailed history of Exane Derivatives transactions in Alteryx, Inc. stock. As of the latest transaction made, Exane Derivatives holds 2,564 shares of AYX stock, worth $0. This represents 0.08% of its overall portfolio holdings.

Number of Shares
2,564
Previous 4,128 37.89%
Holding current value
$0
Previous $295,000 57.97%
% of portfolio
0.08%
Previous 0.09%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 12, 2022

SELL
$44.27 - $74.6 $69,238 - $116,674
-1,564 Reduced 37.89%
2,564 $124,000
Q1 2022

Apr 22, 2022

SELL
$50.8 - $71.82 $56,946 - $80,510
-1,121 Reduced 21.36%
4,128 $295,000
Q4 2021

Jan 28, 2022

SELL
$60.38 - $80.51 $3,381 - $4,508
-56 Reduced 1.06%
5,249 $317,000
Q3 2021

Oct 26, 2021

SELL
$68.51 - $85.07 $53,232 - $66,099
-777 Reduced 12.78%
5,305 $387,000
Q2 2021

Jul 28, 2021

BUY
$74.91 - $89.41 $174,240 - $207,967
2,326 Added 61.93%
6,082 $523,000
Q1 2021

Apr 30, 2021

BUY
$79.46 - $138.66 $153,039 - $267,059
1,926 Added 105.25%
3,756 $311,000
Q4 2020

Jan 27, 2021

SELL
$109.52 - $151.97 $45,998 - $63,827
-420 Reduced 18.67%
1,830 $222,000
Q3 2020

Oct 06, 2020

BUY
$105.71 - $181.98 $237,847 - $409,455
2,250 New
2,250 $255,000

Others Institutions Holding AYX

About Alteryx, Inc.


  • Ticker AYX
  • Exchange NYSE
  • Sector Technology
  • Industry Software—Application
  • Shares Outstandng 60,761,600
  • Description
  • Alteryx, Inc. operates in analytic process automation business in the Asia-Pacific, Europe, the Middle East, Africa, Latin America, and internationally. The company's analytics platform enables organizations to enhance business outcomes and the productivity of their business analysts, data scientists, citizen data scientists, and data engineers....
More about AYX
Track This Portfolio

Track Exane Derivatives Portfolio

Follow Exane Derivatives and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exane Derivatives, based on Form 13F filings with the SEC.

News

Stay updated on Exane Derivatives with notifications on news.